What were the key results from the ADORING 1 and ADORING 2 pivotal trials for tapinarof in terms of efficacy?
Featuring Joshua Zeichner, MD | Director of Cosmetic and Clinical Research Icahn School of Medicine at Mount Sinai New York, NY | Published February 03, 2025
Related Media
Powered by Polaris TM